Medical sales still slow at Toshiba
This article was originally published in Clinica
Sales by Toshiba's (Japan) Information/Communication Systems and Electronic Devices division, which includes medical devices, rose 9.3% to reach ¥,664,627 million ($31,350 million) in the year ended March 31st, 1995. Divisional operating income almost trebled to Yen108,688 million from Yen36,886 million a year earlier. However, the company attributes the rise to personal computers and semiconductors, suggesting that medical sales were as difficult in fiscal 1995 as in fiscal 1994. Group turnover was up 3.5% at Yen4,790,766 million; net income increased 268% to Yen44,693 million.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.